Programmed cell death in the dysmyelinating mutants

R P Skoff1

  • 1Department of Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, MI 48201, USA.

Insights

Genetic mutations affecting myelin proteins can cause central nervous system (CNS) dysmyelination. Proteolipid protein (PLP) gene mutations specifically trigger significant oligodendrocyte (OL) death via apoptosis, confirmed by DNA fragmentation analysis.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Myelin proteins are crucial for nervous system integrity.
  • Mutations in myelin protein genes often lead to dysmyelination in the peripheral (PNS) and central nervous systems (CNS).
  • Oligodendrocyte (OL) survival is generally maintained in myelin mutants, except for those affecting proteolipid protein (PLP).

Purpose of the Study:

  • To investigate the mechanism of oligodendrocyte death in proteolipid protein (PLP) mutants.
  • To determine if programmed cell death (PCD) is involved in OL loss in PLP mutants.
  • To quantify DNA fragmentation as an indicator of PCD in normal and mutant mice.

Main Methods:

  • Analysis of genetic mutants with aberrant myelin protein composition.
  • Microscopic examination of glial cell death and numbers.
  • TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) assay to detect DNA fragmentation in normal and jimpy (jp) mice.
  • Comparison of DNA fragmentation levels with pyknotic glia counts.

Main Results:

  • PLP gene mutations lead to extensive oligodendrocyte (OL) death, correlating with the degree of dysmyelination.
  • Dying OLs in PLP mutants display classical apoptotic features.
  • TUNEL assay revealed significant DNA fragmentation in both normal and jp mice, with specific quantitative differences observed.

Conclusions:

  • Programmed cell death (PCD), indicated by DNA fragmentation, is a key feature of OL loss in PLP mutants.
  • The study supports the role of PCD in nervous system development and myelin disorders.
  • Quantitative analysis of DNA fragmentation provides insights into the extent of cell death in myelin-related neuropathies.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...